| CLDX Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the CLDX shares outstanding history going back to 2/25/2010:
Also see: CLDX Market Cap History CLDX YTD Return |
CLDX Shares Outstanding History — Celldex Therapeutics Share Count Over Time
As of 4/29/2026 Celldex Therapeutics has 78.49 million CLDX shares outstanding. Investors often track the CLDX shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows CLDX share count trends over time, with 68 historical shares outstanding datapoints presented, dating back to 2/25/2010.
| CLDX Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CLDX Historical Shares Outstanding: +25.03% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CLDX Stock Price Chart |
| About Celldex Therapeutics, Inc. |
| Celldex Therapeutics, Inc. is a biopharmaceutical company. Co. is focused on exploring the science of mast cell biology and the development of transformative therapeutics for patients. Its drug candidates include monoclonal and bispecific antibodies designed to address mast cell mediated diseases for which available treatments are inadequate. Its Barzolvolimab, a monoclonal antibody that specifically binds the KIT receptor and potently inhibits its activity, which is studied across multiple mast cell driven diseases, including Chronic Urticarias, Prurigo Nodularis and Eosinophilic Esophagitis. We show 68 historical shares outstanding datapoints in our coverage of CLDX's shares outstanding history. Understanding the changing numbers of CLDX shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like CLDX versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching CLDX by allowing them to research CLDX shares outstanding history as well as any other stock in our coverage universe. |
| CLDX Current Stock Quote |
Quotes delayed 20 minutes  Free CLDX Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| CLDX Share Performance |
| Shares Outstanding Peers |
| Celldex Therapeutics (CLDX) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
CLNN Shares Outstanding History CLOV Shares Outstanding History CLPT Shares Outstanding History CLRB Shares Outstanding History CLSD Shares Outstanding History CLSN Shares Outstanding History CLVS Shares Outstanding History CLXT Shares Outstanding History CLYM Shares Outstanding History CMAX Shares Outstanding History More Healthcare companies » |
CLDX Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
